Linezolid Patent Expiration

1. Zyvox patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6559305 PFIZER Linezolid—crystal form II
Jan, 2021

(3 years ago)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5688792 PFIZER Substituted oxazine and thiazine oxazolidinone antimicrobials
Nov, 2014

(9 years ago)

US5688792

(Pediatric)

PFIZER Substituted oxazine and thiazine oxazolidinone antimicrobials
May, 2015

(9 years ago)

US6559305 PFIZER Linezolid—crystal form II
Jan, 2021

(3 years ago)

US6514529 PFIZER Oxazolidinone tablet formulation
Mar, 2021

(3 years ago)

US6559305

(Pediatric)

PFIZER Linezolid—crystal form II
Jul, 2021

(2 years ago)

US6514529

(Pediatric)

PFIZER Oxazolidinone tablet formulation
Sep, 2021

(2 years ago)




Market Authorisation Date: 18 April, 2000

Treatment: Treatment of microbial infections

Dosage: SOLUTION; FOR SUSPENSION; TABLET

How can I launch a generic of ZYVOX before it's drug patent expiration?
More Information on Dosage

ZYVOX family patents

Family Patents